Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Treatment Group A: Placebo	40
Overall Study	STARTED	Treatment Group B: 2 mg/Day	13
Overall Study	STARTED	Treatment Group C: 4 mg/Day	41
Overall Study	STARTED	Treatment Group D: 8 mg/Day	40
Overall Study	STARTED	Treatment Group E: 12 mg/Day	39
Overall Study	STARTED	Treatment Group F: 24 mg/Day	13
Overall Study	COMPLETED	Treatment Group A: Placebo	33
Overall Study	COMPLETED	Treatment Group B: 2 mg/Day	12
Overall Study	COMPLETED	Treatment Group C: 4 mg/Day	34
Overall Study	COMPLETED	Treatment Group D: 8 mg/Day	32
Overall Study	COMPLETED	Treatment Group E: 12 mg/Day	34
Overall Study	COMPLETED	Treatment Group F: 24 mg/Day	9
Overall Study	NOT COMPLETED	Treatment Group A: Placebo	7
Overall Study	NOT COMPLETED	Treatment Group B: 2 mg/Day	1
Overall Study	NOT COMPLETED	Treatment Group C: 4 mg/Day	7
Overall Study	NOT COMPLETED	Treatment Group D: 8 mg/Day	8
Overall Study	NOT COMPLETED	Treatment Group E: 12 mg/Day	5
Overall Study	NOT COMPLETED	Treatment Group F: 24 mg/Day	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01485172/flow